Twist Bioscience Investors Seek $17M Stock Fraud Deal OK
Twist Bioscience Corp. and two executives asked a California federal court to give preliminary approval to a $17 million deal they inked with investors to resolve class allegations the company misrepresented...To view the full article, register now.
Already a subscriber? Click here to view full article